Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph receptors: Correlation to function in a growth cone collapse assay
Article first published online: 2 JAN 2009
Copyright © 2007 The Protein Society
Volume 16, Issue 3, pages 355–361, March 2007
How to Cite
Pabbisetty, K. B., Yue, X., Li, C., Himanen, J.-P., Zhou, R., Nikolov, D. B. and Hu, L. (2007), Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph receptors: Correlation to function in a growth cone collapse assay. Protein Science, 16: 355–361. doi: 10.1110/ps.062608807
- Issue published online: 2 JAN 2009
- Article first published online: 2 JAN 2009
- Manuscript Accepted: 16 DEC 2006
- Manuscript Revised: 8 DEC 2006
- Manuscript Received: 12 OCT 2006
- 2005. Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition. Structure 13: 825–832. , , and
- 2002. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21: 7011–7026. , , , , , , , , , and , et al.
- 1994. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266: 816–819. , , , , , , , and
- 2005. Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. J. Biol. Chem. 280: 26526–26532. , , , , , , and
- 2000. Eph receptors and ephrin ligands: Embryogenesis to tumorigenesis. Oncogene 19: 5614–5619. and
- 1995. In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell 82: 359–370. , , , , , and
- Eph Nomenclature Committee 1997. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 90: 403–404.
- 1998. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21: 309–345. and
- 2004. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin. Chem. 50: 490–499. , , , , , , , , and
- 2003. Eph signaling: A structural view. Trends Neurosci. 26: 46–51. and
- 2004. Repelling class discrimination: Ephrin-A5 binds to and activates EphB2 receptor signaling. Nat. Neurosci. 7: 501–509. , , , , , , , , , and , et al.
- 1997. Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor. J. Biol. Chem. 272: 16521–16530. , , , , , , , , , and , et al.
- 1998. Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization. J. Biol. Chem. 273: 20228–20237. , , , , , , , and
- 1998. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. Engl. 37: 2755–2794. , , and
- 2003. ‘Eph’ective signaling: Forward, reverse and crosstalk. J. Cell Sci. 116: 2823–2832. and
- 2000. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19: 6043–6052. , , , , , and
- 2005. EPH receptor signaling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol. 6: 462–475.
- 2004. Diverse roles of Eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev. Cell 7: 465–480. , , and
- 1998. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes & Dev. 12: 667–678. , , , , , , and
- 2001. Temporally compartmentalized expression of ephrin-B2 during renal glomerular development. J. Am. Soc. Nephrol. 12: 2673–2682. , , , , , and
- 1999. High level expression of EPHB6, EFNB2 and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastoma. Clin. Cancer Res. 5: 1491–1496. , , , , , , , , and
- 1998. Overexpression of Lerk-5/Eplg5 messenger RNA: A novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin. Cancer Res. 4: 791–797. , , , , , , , and